'INC'

'-  Participants with accessible lesions enrolled in selected pharmacokinetic ( PK ) / pharmacodynamics ( PD ) cohorts and in Part 2 must agree to undergo the mandatory fresh tumor biopsies , unless collection of the biopsy presents a safety risk'

'-  Participants with accessible obs("lesions") enrolled in selected pharmacokinetic ( PK ) / pharmacodynamics ( PD ) cohorts and in Part 2 must agree to undergo the mandatory fresh tumor biopsies , unless collection of the biopsy presents a safety risk'

obs("lesions")